Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Antony Blinken cancels China trip following discovery of spy balloon
    • US accuses China of flying spy balloon over sensitive military sites
    • US jobs total surges by over half a million in January
    • Madison Square Garden owner battles outcry over ‘dystopian’ blacklisting
    • Nigeria’s attempt to replace its currency notes descends into chaos
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • TotalEnergies says exposure to Adani stands at $3.1bn as turmoil mounts
      • Billionaire Disney insider becomes pivotal figure in Nelson Peltz’s proxy fight
      • EY considers handing retired US partners cut of proceeds from spin-off
      • BT chief warns Openreach fibre push will ‘end in tears’ for rivals
      • Carlyle courts ex-Goldman executive Harvey Schwartz for CEO
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Live news updates from February 3: US jobs gains surge unexpectedly, FTSE 100 hits record high
      • UK’s FTSE 100 share index beats 2018 peak to hit all-time high
      • The battle for the Colorado River is a water warning to us all
      • Nigeria’s attempt to replace its currency notes descends into chaos
      • Nasdaq closes 3.3% higher as investors bet rates are close to peak levels
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
      Most Read
      • The return of the ‘British disease’
      • Britain should not accept its status as the ‘sick man of Europe’
      • OK boomer, you’re more generous than we thought
      • How to fix the British economy
      • What chimpanzees tell us about how humans see data
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • A new generation refuses to keep quiet on age discrimination at work
      • Shoshana Zuboff: ‘Privacy has been extinguished. It is now a zombie’
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Germany grapples with the limits of pacifism
      • After hours with 10 Foot, London’s most notorious graffiti writer
      • Rugby superstar Siya Kolisi: ‘I’ve got no ego at all’
      • Retiring at 62? The French have it absolutely right
      • Bill Gates is probed and baited in BBC interview with Amol Rajan — TV review
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Disease control and prevention

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Friday, 3 February, 2023
      Medical science
      First heart patients diagnosed using new fibre optic technology

      Researchers say device developed in London could help thousands suffering from vascular disease

    • Thursday, 2 February, 2023
      Medical science
      Neural implants in rats pave way to treat brain injuries

      Neuroscience breakthrough demonstrates ability of human organoids to adopt functions of host’s visual cortex

    • Sunday, 29 January, 2023
      Drugs research
      RQ Bio partners with AstraZeneca in Covid antibody fight

      UK biotech racing to keep antibody up to date with latest variants

    • Thursday, 26 January, 2023
      UK universities
      Lack of clinical academics threatens NHS research and teaching, say peers

      Shortage of doctors with university posts is putting health service on ‘dangerous precipice’

    • Tuesday, 24 January, 2023
      Kate Bingham
      Britain is losing its chance to become a life sciences superpower

      Short-termism and suspicion in parts of government risk our valuable future in precision medicine

    • Monday, 23 January, 2023
      News in-depthCoronavirus treatment
      Rural China runs short of Covid drugs over lunar new year holiday

      Officials row with Pfizer over price as villages struggle to obtain antiviral medication

    • Tuesday, 17 January, 2023
      InterviewJenny Harries
      Covid will ‘taunt us’ for years, says UK health security chief

      Future of pandemic less predictable than at the outset because of new variants, says Jenny Harries

    • Sunday, 15 January, 2023
      Coronavirus pandemic
      WHO calls on China to release more data on Covid outbreak

      Beijing reports almost 60,000 deaths in month since abandoning pandemic restrictions

    • Friday, 13 January, 2023
      Wes Streeting
      Only radical thinking can find a long-term cure for the NHS

      Starting with primary care, investment combined with modernisation can deliver better outcomes for patients

    • Thursday, 12 January, 2023
      EU economy
      EU draws up plans to stockpile scarce medicines

      Effort to improve health supply chain issues that have led to Greece imposing an export ban on drugs

    • Wednesday, 11 January, 2023
      Anjana Ahuja
      New Alzheimer’s drug straddles uneasy gulf between help and harm

      For all its landmark status, lecanemab may end up representing a triumph of hope over evidence

    • Tuesday, 10 January, 2023
      BioNTech
      BioNTech buys UK AI start-up InstaDeep in £562mn deal

      Covid vaccine maker looks to use machine learning to help discover new treatments

    • Tuesday, 10 January, 2023
      Covid-19 vaccines
      Chinese bank tries to entice wealthy customers with mRNA vaccines

      Hong Kong-based lender seeks to cater to mainlanders’ demand for western jabs

    • Tuesday, 10 January, 2023
      Coronavirus pandemic
      China suspends travel visas from Japan and S Korea over Covid curbs

      Beijing accuses countries of ‘political manipulation’ for introducing testing requirements during exit wave

    • Tuesday, 10 January, 2023
      Coronavirus pandemic
      China’s Covid patients face medical debt crisis as insurers refuse coverage

      Narrow definition of cases leaves claimants on the hook after state-backed policies drop free care

    • Monday, 9 January, 2023
      Disrupted Times
      World awaits return of Chinese tourists

      Also in this edition: eurozone unemployment falls to new low, uproar in Brazil and Rolls-Royce hits sales record

    • Monday, 9 January, 2023
      CureVac GmbH
      Covid vaccine makers CureVac and Novavax appoint new chiefs

      Pharmaceutical groups to part ways with longstanding executives

    • Monday, 9 January, 2023
      InterviewPharmaceuticals sector
      SK Bioscience says ‘national pride’ prevents China from accepting foreign Covid jabs

      South Korean vaccine maker looks elsewhere to expand overseas business

    • Sunday, 8 January, 2023
      Medical science
      Alphabet’s Verily seeks to eradicate dengue in Singapore

      Bid to extend tech throughout city state to wipe out disease-carrying mosquito population

    • Friday, 6 January, 2023
      Pharmaceuticals sector
      US approves Alzheimer’s drug that slows rate of cognitive decline

      High price of treatment and restrictions on medicine developed by Eisai and Biogen will limit patient access initially

    • Friday, 6 January, 2023
      Covid-19 vaccines
      New Chinese mRNA Covid vaccine shows positive early results

      Jab developed by CanSinoBio could help nation grappling with a wave of infection

    • Friday, 6 January, 2023
      Coronavirus economic impact
      Ambulances left waiting for record times as ‘twindemic’ hits UK

      Covid and flu hospitalisations soar over Christmas as emergency service delays worsen

    • Friday, 6 January, 2023
      News in-depthDrugs research
      A pharma partnership that brought a breakthrough in breast cancer

      Daiichi Sankyo and AstraZeneca’s Enhertu could double time patients can live without their condition progressing

    • Friday, 6 January, 2023
      Medical science
      UK signs deal with BioNTech for cutting-edge cancer trials

      Covid-19 vaccine maker hails ‘huge’ investment aimed at recruiting 10,000 participants with NHS

    • Thursday, 5 January, 2023
      OutlookPatti Waldmeir
      The surprising Covid legacy for America’s homeschoolers

      While most children are back to the old routine, 3.7mn US households are still teaching their kids at home

    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition
    • Top sections
    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports
    • FT recommends
    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • FTfm
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In